Expression of the epidermal growth factor system in endometrioid endometrial cancer (Q80234179)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Expression of the epidermal growth factor system in endometrioid endometrial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Steen S. Poulsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Axel Forman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ebba Nexø

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Kirsten Ejskjaer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ole Mogensen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

7 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

158-167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

ErbB-4: mechanism of action and biology

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

The deaf and the dumb: the biology of ErbB-2 and ErbB-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

The ErbB receptors and their role in cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Expression of the epidermal growth factor system in human endometrium during the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Cancer of the endometrium: current aspects of diagnostics and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Current treatment options for endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Dexamethasone attenuates the estradiol-induced increase of IGF-I mRNA in the rat uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

HER-2/neu amplification and overexpression in endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Immunohistochemically detected HER-2/neu-expression and prognosis in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Expression of epidermal growth factor receptors in human endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Review of epidermal growth factor receptor biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

The ErbB signaling network: receptor heterodimerization in development and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

ErbB receptors: directing key signaling networks throughout life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Neuregulins: functions, forms, and signaling strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

The activation of an extracellular signal-regulated kinase by oestradiol interferes with the effects of trastuzumab on HER2 signalling in endometrial adenocarcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

Requirements for estrogen receptor alpha membrane localization and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.07.015

10.1016/J.YGYNO.2006.07.015

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16962163%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference